USP7 and neoplasm: While analyzing the genomic landscape of pediatric T-ALL, we discovered a high frequency of heterozygous LOF mutations of USP7 in the TAL1 subgroup5,7,49, raising questions regarding the molecular basis for haploinsufficient tumor suppressor activity of USP7 in this malignancy.